Cardiol Therapeutics (CRDL) Exchange Rate Effect (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Exchange Rate Effect came in at $161840.6 in Q1 2026, up 315.47% YoY from $38954.1 in Q1 2025, and down 39.68% on a QoQ basis from $268294.7 in Q3 2025.
Cardiol Therapeutics (CRDL) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Exchange Rate Effect data on file, last reported at $161840.6 in Q1 2026.
- Quarterly Exchange Rate Effect rose 315.47% year-over-year to $161840.6 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49895.1 (down 135.95% YoY) and the FY2021 annual result came in at $66.9 million, up 539.45% from the prior year.
- Exchange Rate Effect slipped to $161840.6 in Q1 2026, from $268294.7 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.1 million in Q1 2022 to a low of -$2.5 million in Q3 2022.
- A 5-year average of -$208119.9 and a median of $2041.6 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect jumped 17751.51% — and 2025, when it sank 470.0%.
- Tracing CRDL's Exchange Rate Effect over 5 years: stood at -$2.5 million in 2022, then jumped by 70.61% to -$722212.1 in 2023, then soared by 64.0% to -$259981.1 in 2024, then surged by 203.2% to $268294.7 in 2025, then plunged by 39.68% to $161840.6 in 2026.
- The last three Exchange Rate Effect figures came in at $161840.6 (Q1 2026), $268294.7 (Q3 2025), and -$404918.2 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Cardiol Therapeutics | 213.21 Mn | 194.35 Mn | - | 226,353.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 161,840.64 |
| Mar 31, 2026 | 161,840.64 |
| Sep 30, 2025 | 268,294.72 |
| Sep 30, 2025 | 268,294.72 |
| Jun 30, 2025 | -404,918.24 |
| Jun 30, 2025 | -404,918.24 |
| Mar 31, 2025 | -75,112.26 |
| Mar 31, 2025 | -75,112.26 |
| Sep 30, 2024 | -259,981.06 |
| Sep 30, 2024 | -259,981.06 |
| Jun 30, 2024 | 109,437.85 |
| Jun 30, 2024 | 109,437.85 |
| Mar 31, 2024 | 364,449.57 |
| Mar 31, 2024 | 364,449.57 |
| Sep 30, 2023 | -722,212.12 |
| Sep 30, 2023 | -722,212.12 |
| Jun 30, 2023 | 630,201.35 |
| Jun 30, 2023 | 630,201.35 |
| Mar 31, 2023 | 2,041.56 |
| Mar 31, 2023 | 2,041.56 |